MyOme
My Genome. My Health. MyOme.
San Francisco, United States · Founded 2017 · $23.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- myome.com
- Total Funding
- $23.0M
- Last Round
- $23.0M Corporate RoundDec 2025
- Rounds
- 3
About
MyOme is a clinical whole genome analysis platform helping patients and providers understand genetic risk for inherited diseases. Using whole genome sequencing and proprietary bioinformatics, MyOme produces actionable reports covering rare disease, medication response, and polygenic risk. Founded in 2017 and based in San Francisco.
Summary
MyOme is a Biotech company based in San Francisco, United States, founded in 2017. It has raised $23.0M in total across 3 rounds, most recently a $23.0M Corporate Round round in Dec 2025. Investors include Illumina Ventures, Healthcare Venture Partners and HOF Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...